Most normal cells and tissues preferentially utilize circulating lipids, whereas cancer cells predominantly rely on the de novo fatty acid synthesis pathway to enhance membrane lipid saturation and helps cancer cells to survive both carcinogenic and therapeutic challenges (7, 8).ACLY is a pivotal enzyme at the crossroads of glucose and lipid metabolism. Here, ACLY is linked to cancer.